Filing search / Incannex Healthcare Limited / "Innovate"

S-1/A

IXHL Incannex Healthcare Limited

17 Jul 24

IPO registration (amended)

8:47am

of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks

S-1

IXHL Incannex Healthcare Limited

3 Jul 24

IPO registration

6:29am

to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms

6-K

EX-99.1

IXHL Incannex Healthcare Limited

18 May 23

Report of Foreign Private Issuer

8:00am

is focused on a rigorous program of research in clinical psychedelics that seeks to innovate on treatment design, evaluate therapeutic effects, mitigate

20-F

2022 FY

IXHL Incannex Healthcare Limited

28 Oct 22

Annual report (foreign)

6:31am

University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand

6-K

EX-99.1

qkg3rkne 7m46s3jo

19 Sep 22

Report of Foreign Private Issuer

9:38pm

20FR12B/A

qi8b0se

24 Feb 22

Initial registration of securities (foreign private issuers) (amended)

3:42pm

20FR12B/A

buycd3j mbbr6tyw2853

22 Feb 22

Initial registration of securities (foreign private issuers) (amended)

6:10am

20FR12B

ryr9p

24 Jan 22

Initial registration of securities (foreign private issuers)

8:18pm

F-1/A

0wywe7x 2q9faopkd

7 Dec 21

Registration statement (foreign) (amended)

5:21pm

F-1/A

r6vqz77za4tlc2orerj3

23 Nov 21

Registration statement (foreign) (amended)

3:28pm

F-1/A

oi18jhjclkl7zpf6mni7

3 Nov 21

Registration statement (foreign) (amended)

6:06am

F-1/A

mantekbklphfuxzmy

28 Sep 21

Registration statement (foreign) (amended)

6:06am

F-1

t8jc93 9r76t6w

17 Aug 21

Registration statement (foreign)

4:39pm